When you buy through links on our articles, Future and its syndication partners may earn a commission.
The PACK trial 1 was a parallel-arm cluster randomised trial, assigning 48 clinics to the intervention arm (a training ...
Walters: They are simple and transparent, eliminate inherent bias and can clearly show whether version A or B of a product ...
Volta Medical put forward new data showing its artificial intelligence-guided ablation procedures were able to improve ...
Semaglutide (Wegovy) may help heavy drinkers cut down on their alcohol intake in addition to losing weight, a trial has found ...
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.
Updated data from the Phase III TALAPRO-2 trial show that the combination of Talzenna (talazoparib) and Xtandi (enzalutamide) significantly improves overall survival in patients with metastatic ...
A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...
9h
Verywell Health on MSNI’m a Health Editor and I Tried Lemme Chill Gummies for 2 Weeks for AnxietyKourtney Kardashian's Lemme Chill gummies are marketed for de-stressing. Here's what happened to my anxiety when I took them ...
‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results